Arbutus Biopharma(DE:I9DN)
€3.45+0.06 (+1.80%)
DE:I9DN
Arbutus Biopharma earnings date
€3.45
At close:+0.06 (+1.80%)
Arbutus Biopharma (I9DN) Q2 2023 Earnings Report
1 Followers
DE:I9DN Q2 2023 EPS Results
- Actual EPS
- -EUR 0.09
- Consensus EPS
- -EUR 0.10
- Beat/Miss
- Beat by +EUR 0.01
- One Year Ago EPS
- -EUR 0.09
DE:I9DN Q2 2023 Revenue Results
- Actual Revenue
- EUR 4.16M
- Expected Revenue
- EUR 5.53M
- Beat/Miss
- Missed by -EUR 1.37M
- YoY Revenue Growth
- -67.34%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/03/2023
- Time
- Before Open
- Conference Call
- Thursday, August 3, 2023
DE:I9DN Upcoming Earnings
Arbutus Biopharma's next earnings date is estimated for March 4, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
DE:I9DN Q2 2023 Earnings Call
0:00 / 0:00
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:I9DN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 04, 2027 | 2026 (Q4) | -0.02- | -0.01 | ― | ― |
| Nov 10, 2026 | 2026 (Q3) | -0.020.27 | -0.04 | 850.00% (+0.30) | |
| Aug 12, 2026 | 2026 (Q2) | -0.02-0.03 | 0.01 | -400.00% (-0.04) | |
| May 13, 2026 | 2026 (Q1) | -0.030.78 | -0.12 | 769.23% (+0.90) | |
| Mar 23, 2026 | 2025 (Q4) | -0.03-0.01 | -0.06 | 85.71% (+0.05) | |
| Nov 13, 2025 | 2025 (Q3) | -0.03-0.04 | -0.09 | 60.00% (+0.05) | |
| Aug 06, 2025 | 2025 (Q2) | -0.040.01 | -0.1 | 109.09% (+0.11) | |
| May 14, 2025 | 2025 (Q1) | -0.09-0.12 | -0.09 | -30.00% (-0.03) | |
| Mar 27, 2025 | 2024 (Q4) | -0.07-0.06 | -0.11 | 41.67% (+0.04) | |
| Nov 06, 2024 | 2024 (Q3) | -0.08-0.09 | -0.11 | 16.67% (+0.02) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
